Annual report [Section 13 and 15(d), not S-K Item 405]

Note 11 - Stock Based Compensation - Stock Option Activity (Details)

v3.25.1
Note 11 - Stock Based Compensation - Stock Option Activity (Details) - The 2023 Equity Plan [Member] - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Options, outstanding (in shares)   465,500 0  
Options, outstanding, weighted average exercise price (in dollars per share)   $ 9.36 $ 0  
Options, outstanding, aggregate intrinsic value   $ 1,106 $ 70 $ 0
Granted, options (in shares) 465,500 58,000 465,500  
Granted, weighted average exercise price (in dollars per share)   $ 11.34 $ 9.36  
Exercised, options (in shares)   (23,000) 0  
Exercised, weighted average exercise price (in dollars per share)   $ 9.36 $ 0  
Forfeited, options (in shares)   0 0  
Forfeited, weighted average exercise price (in dollars per share)   $ 0 $ 0  
Exercisable, options (in shares)   106,900 23,000  
Exercisable, weighted average exercise price (in dollars per share)   $ 9.36 $ 9.36  
Exercisable, aggregate intrinsic value [1]   $ 261 $ 3 [2]  
Options, outstanding (in shares)   500,500 465,500  
Options, outstanding, weighted average exercise price (in dollars per share)   $ 9.59 $ 9.36  
[1] Dollars in thousands. The aggregate intrinsic value of outstanding and exercisable options at September 30, 2023 and 2024 were calculated based on the closing market price of the Company's common stock of September 30, 2023 and 2024 of $10.35 and $9.05, respectively, per share less the exercise price.
[2] Dollars in thousands. The aggregate intrinsic value of outstanding and exercisable options at September 30, 2023 and 2024 were calculated based on the closing market price of the Company's common stock of September 30, 2023 and 2024 of $10.35 and $9.05, respectively, per share less the exercise price.